StockData

Research Alliance Corp III (RACC) stock

RACCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$10.12−0.03 (-0.30%)

Close on Nov 12, 2026Market cap $92.08MP/E –Yield –

Key statistics

Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026

Valuation

Market cap
$92.08M
P/E ratio
–
Price to sales
–
Price to book
–
Dividend yield
–
Free cash flow yield
–

Trading

Previous close
$10.15
Open
$10.16
Day's range
$10.12 – $10.16
Volume
51,436
Average volume (20 days)
40,853
RSI (14 days)
28.9
Volatility (1 year)
91.4%
Relative volume
0.71×

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

PeriodRACCS&P 500DifferenceRACC per yearS&P 500 per year
1 month-0.6%-2.7%+2.1 pts
3 months-65.5%-1.7%−63.7 pts

Press releases

Releases Research Alliance Corp III filed with the SEC as exhibits to Form 8-K or 6-K

Research Alliance Corp III stock: common questions

What is Research Alliance Corp III's stock price?

RACC closed at $10.12 on Nov 12, 2026, down 0.30% on the day.

What is Research Alliance Corp III's market cap?

Research Alliance Corp III was worth $92.08M at the close on Nov 12, 2026: the share price times the diluted shares outstanding.

Does Research Alliance Corp III pay a dividend?

No. Research Alliance Corp III has not paid a cash dividend over the last twelve months.

How many RACC shares are sold short?

0M shares were sold short at the latest FINRA report, 0.10% of the float, or 1.0 days of average trading volume.

Who are Research Alliance Corp III's competitors?

Companies most similar to Research Alliance Corp III by business, industry and size include LLY, JNJ, ABBV, MRK, AZN.

See a number that looks wrong?